Advisory Research Inc Biomarin Pharmaceutical Inc Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $197,139 - $359,415	-2,743 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $218,205 - $340,735	2,743 New	2,743 $338,000
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $202,585 - $237,279	-2,406 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $192,816 - $255,204	2,406 New	2,406 $205,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.